Insider · CIK 0001578200

Schenkein David P

CIK 0001578200 Name as filed on the most recent filing

Filed as Schenkein David P (64)

112 transaction lines · from 64 filings · filed 2014-07-02 to 2024-11-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

112 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2018-01-16 S, Open-market sale Agios Pharmaceuticals IncAGIO 808,837, disposed Open Form 4 filing 0001209191-18-003637
2018-01-16 S, Open-market sale Agios Pharmaceuticals IncAGIO 493,456, disposed Open Form 4 filing 0001209191-18-003637
2017-12-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 369,288, disposed Open Form 4 filing 0001209191-17-063927
2017-11-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 4 lines 383,105, disposed Open Form 4 filing 0001209191-17-059135
2017-10-04 S, Open-market sale Agios Pharmaceuticals IncAGIO 5,611,200, disposed Open Form 4 filing 0001209191-17-056191
2017-10-02 S, Open-market sale Agios Pharmaceuticals IncAGIO 400,560, disposed Open Form 4 filing 0001209191-17-055844
2017-09-18 S, Open-market sale Agios Pharmaceuticals IncAGIO 2,349,200, disposed Open Form 4 filing 0001209191-17-053461
2017-09-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 373,200, disposed Open Form 4 filing 0001209191-17-051430
2017-08-31 S, Open-market sale bluebird bio, Inc.BLUE 230,145, disposed Open Form 4 filing 0001209191-17-051251
2017-08-02 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,453,200, disposed Open Form 4 filing 0001209191-17-047452
2017-08-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 165,360, disposed Open Form 4 filing 0001209191-17-047452
2017-07-03 S, Open-market sale Agios Pharmaceuticals IncAGIO 153,540, disposed Open Form 4 filing 0001209191-17-044054
2017-06-07 S, Open-market sale Agios Pharmaceuticals IncAGIO 95,038, disposed Open Form 4 filing 0001209191-17-038521
2017-06-06 S, Open-market sale Agios Pharmaceuticals IncAGIO 55,022, disposed Open Form 4 filing 0001209191-17-038521
2017-05-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 150,180, disposed Open Form 4 filing 0001209191-17-029168
2017-04-03 S, Open-market sale Agios Pharmaceuticals IncAGIO 175,860, disposed Open Form 4 filing 0001209191-17-025572
2017-03-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 151,410, disposed Open Form 4 filing 0001209191-17-017611
2017-03-01 S, Open-market sale bluebird bio, Inc.BLUE 447,633, disposed Open Form 4 filing 0001209191-17-017513
2017-02-16 S, Open-market sale Agios Pharmaceuticals IncAGIO 300,060, disposed Open Form 4 filing 0001209191-17-012144
2015-10-27 S, Open-market sale Agios Pharmaceuticals IncAGIO 321,040, disposed Open Form 4 filing 0001209191-15-077349
2015-08-03 S, Open-market sale Agios Pharmaceuticals IncAGIO 884,800, disposed Open Form 4 filing 0001209191-15-064104
2015-06-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 1,568,710, disposed Open Form 4 filing 0001209191-15-049127
2015-05-27 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,071,926, disposed Open Form 4 filing 0001209191-15-047616
2015-05-12 S, Open-market sale Agios Pharmaceuticals IncAGIO 230,293, disposed Open Form 4 filing 0001209191-15-042307
2015-05-11 S, Open-market sale Agios Pharmaceuticals IncAGIO 341,801, disposed Open Form 4 filing 0001209191-15-042307
2015-05-08 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 395,148, disposed Open Form 4 filing 0001209191-15-041230
2015-05-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 365,157, disposed Open Form 4 filing 0001209191-15-038933
2015-04-13 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 390,117, disposed Open Form 4 filing 0001209191-15-034353
2015-04-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 360,906, disposed Open Form 4 filing 0001209191-15-032432
2015-03-05 S, Open-market sale Agios Pharmaceuticals IncAGIO 286,416, disposed Open Form 4 filing 0001209191-15-024216
2015-03-02 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 834,990, disposed Open Form 4 filing 0001209191-15-021473
2015-02-13 S, Open-market sale Agios Pharmaceuticals IncAGIO 82,292, disposed Open Form 4 filing 0001209191-15-013754
2015-02-11 S, Open-market sale Agios Pharmaceuticals IncAGIO 94,550, disposed Open Form 4 filing 0001209191-15-013754
2015-02-02 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 1,188,824, disposed Open Form 4 filing 0001209191-15-009105
2015-01-02 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 1,431,040, disposed Open Form 4 filing 0001209191-15-002392
2014-12-19 P, Open-market purchase bluebird bio, Inc.BLUE 99,960, acquired Open Form 4 filing 0001209191-14-077222
2014-12-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 1,261,390, disposed Open Form 4 filing 0001209191-14-072463
2014-11-03 S, Open-market sale Agios Pharmaceuticals IncAGIO 2 lines 1,062,230, disposed Open Form 4 filing 0001209191-14-066366

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 110
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Schenkein David P, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001578200

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.